AIxMed Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 29

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $2.75M

  • Investors
  • 2

AIxMed General Information

Description

Operator of a digital cytology platform intended to improve patient care and outcomes. The company's artificial intelligence (AI) powered computational platform provides bladder cancer monitoring and assisted diagnosis, enabling healthcare professionals to remove diagnostic and monitoring complexity and reduce unnecessary cancer-related costs.

Contact Information

Website
www.aixmed.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 2975 Scott Boulevard
  • Suite 110
  • Santa Clara, CA 95054
  • United States
+1 (510)
Primary Industry
Diagnostic Equipment
Other Industries
Other Healthcare Services
Other Healthcare Technology Systems
Vertical(s)
Artificial Intelligence & Machine Learning, HealthTech, Life Sciences, Oncology
Corporate Office
  • 2975 Scott Boulevard
  • Suite 110
  • Santa Clara, CA 95054
  • United States
+1 (510)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

AIxMed Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Later Stage VC 27-Apr-2023 $2.75M Completed Generating Revenue
1. Early Stage VC (Series A) 15-Apr-2022 Completed Generating Revenue
To view AIxMed’s complete valuation and funding history, request access »

AIxMed Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate ($) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series A-4
Series A-3
Series A-2 1,714,228 $0.000010 $0.04 $0.58 $0.58 1x $0.58 6.1%
Series A-1 2,651,691 $0.000010 $0.04 $0.62 $0.62 1x $0.62 9.44%
To view AIxMed’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

AIxMed Patents

  • 18

    Total Documents Applications and Grants

  • Total Patents Families

  • 12

    Granted

  • 4

    Pending

  • Expiring in next 12 mo

AIxMed Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025250478-A1 Method and system to obtain images of target cells in cytopathology Pending 26-May-2024
JP-2025535867-A Method and system for obtaining sufficient cytological images in cytopathology Active 02-Sep-2022
JP-7915456-B2 Method and system for obtaining sufficient cytological images in cytopathology Active 02-Sep-2022
EP-4581572-A1 Method and system to obtain sufficient cytology image in cytopathology Pending 02-Sep-2022
EP-4581572-A4 Method and system to obtain sufficient cytology image in cytopathology Pending 02-Sep-2022 G06T7/0012
To view AIxMed’s complete patent history, request access »

AIxMed Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

AIxMed Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Black Marble Capital Management Venture Capital Minority
Taiwania Capital Management Venture Capital Minority
To view AIxMed’s complete investors history, request access »

Ready to get started?

Request a free trial

AIxMed FAQs

  • When was AIxMed founded?

    AIxMed was founded in 2018.

  • Where is AIxMed headquartered?

    AIxMed is headquartered in Santa Clara, CA.

  • What is the size of AIxMed?

    AIxMed has 29 total employees.

  • What industry is AIxMed in?

    AIxMed’s primary industry is Diagnostic Equipment.

  • Is AIxMed a private or public company?

    AIxMed is a Private company.

  • What is AIxMed’s current revenue?

    The current revenue for AIxMed is .

  • How much funding has AIxMed raised over time?

    AIxMed has raised $11M.

  • Who are AIxMed’s investors?

    Black Marble Capital Management and Taiwania Capital Management have invested in AIxMed.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process